2022
DOI: 10.1111/cas.15480
|View full text |Cite
|
Sign up to set email alerts
|

Novel prognostic model predicts overall survival in colon cancer based on RNA splicing regulation gene expression

Abstract: Colon cancer is the third most common cancer and the second leading cause of cancer‐related death worldwide. Dysregulated RNA splicing factors have been reported to be associated with tumorigenesis and development in colon cancer. In this study, we interrogated clinical and RNA expression data of colon cancer patients from The Cancer Genome Atlas (TCGA) dataset and the Gene Expression Omnibus (GEO) database. Genes regulating RNA splicing correlated with survival in colon cancer were identified and a risk score… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 52 publications
(101 reference statements)
0
2
0
Order By: Relevance
“…Additionally, this model was confirmed as a predictor of therapeutic efficacy in CC. Among these genes, TIMP1 [ 50 ], FSTL3 [ 51 ], SLC2A3 [ 52 ], and TNNT1 [ 53 ] have been reported to be closely associated with the progression and prognosis of CC. The role of FABP4 in regulating the progression of CC is still controversial[ 54 , 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, this model was confirmed as a predictor of therapeutic efficacy in CC. Among these genes, TIMP1 [ 50 ], FSTL3 [ 51 ], SLC2A3 [ 52 ], and TNNT1 [ 53 ] have been reported to be closely associated with the progression and prognosis of CC. The role of FABP4 in regulating the progression of CC is still controversial[ 54 , 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…As demonstrated by studies, AKAP8L stimulates cell proliferation / migration in various cancers, such a sd colon cancer, gastric cancer and esophageal squamous cell carcinoma, and can interact with mTORC1 and promote cell growth. Thus, it may be a prospective target for the treatment of cancers [ 9 , 15 , 16 , 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…hand. The 6 up-regulated genes (IL-20, CLK1, SORBS2, ERG1, PIM1, SNORD3A) are involved in cancer development [43][44][45][46][47][48]. Interleukin 20 (IL-20) is a cytokine assigned to the interleukin 10 family described as tumor promoting [49].…”
Section: Plos Onementioning
confidence: 99%